Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer.
Díaz-Riascos ZV, Llaguno-Munive M, Lafuente-Gómez N, Luengo Y, Holmes S, Volatron J, Ibarrola O, Mancilla S, Sarno F, Aguirre JJ, Razafindrakoto S, Southern P, Terán FJ, Keogh A, Salas G, Prina-Mello A, Lacal JC, Del Pozo A, Pankhurst QA, Hidalgo M, Gazeau F, Somoza Á, Schwartz S Jr, Abasolo I. Díaz-Riascos ZV, et al. Among authors: sarno f. ACS Appl Mater Interfaces. 2025 Jan 15;17(2):2924-2939. doi: 10.1021/acsami.4c16129. Epub 2025 Jan 2. ACS Appl Mater Interfaces. 2025. PMID: 39745145
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.
Sarno F, Tenorio J, Perea S, Medina L, Pazo-Cid R, Juez I, Garcia-Carbonero R, Feliu J, Guillen-Ponce C, Lopez-Casas PP, Guerra C, Duran Y, López-Acosta JF, Alonso C, Esquivel E, Dopazo A, Akshinthala D, Muthuswamy SK, Lapunzina P, Bockorny B, Hidalgo M. Sarno F, et al. Clin Cancer Res. 2025 Jan 17;31(2):278-287. doi: 10.1158/1078-0432.CCR-23-4026. Clin Cancer Res. 2025. PMID: 39540844 Free PMC article. Clinical Trial.
Cancer Therapy Resistance: Choosing Kinase Inhibitors.
Dell'Aversana C, Sarno F, Benedetti R, Megchelenbrink WL, Cappetta D. Dell'Aversana C, et al. Among authors: sarno f. Pharmaceutics. 2024 Mar 7;16(3):373. doi: 10.3390/pharmaceutics16030373. Pharmaceutics. 2024. PMID: 38543267 Free PMC article.
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447.
Zwergel C, Fioravanti R, Stazi G, Sarno F, Battistelli C, Romanelli A, Nebbioso A, Mendes E, Paulo A, Strippoli R, Tripodi M, Pechalrieu D, Arimondo PB, De Luca T, Del Bufalo D, Trisciuoglio D, Altucci L, Valente S, Mai A. Zwergel C, et al. Among authors: sarno f. Cancers (Basel). 2024 Mar 21;16(6):1230. doi: 10.3390/cancers16061230. Cancers (Basel). 2024. PMID: 38539577 Free PMC article.
In-silico guided chemical exploration of KDM4A fragments hits.
Lombino J, Vallone R, Cimino M, Gulotta MR, De Simone G, Morando MA, Sabbatella R, Di Martino S, Fogazza M, Sarno F, Coronnello C, De Rosa M, Cipollina C, Altucci L, Perricone U, Alfano C. Lombino J, et al. Among authors: sarno f. Clin Epigenetics. 2023 Dec 21;15(1):197. doi: 10.1186/s13148-023-01613-7. Clin Epigenetics. 2023. PMID: 38129913 Free PMC article.
65 results